Hamilton Wealth LLC Purchases 193 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Hamilton Wealth LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 72.0% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 461 shares of the biopharmaceutical company’s stock after buying an additional 193 shares during the quarter. Hamilton Wealth LLC’s holdings in Regeneron Pharmaceuticals were worth $444,000 at the end […]
More Stories
Sysco (NYSE:SYY) Price Target Raised to $88.00
Sysco (NYSE:SYY – Free Report) had its price target increased by JPMorgan Chase & Co. from $85.00 to $88.00 in...
Trio-Tech International (NYSE:TRT) Research Coverage Started at StockNews.com
StockNews.com initiated coverage on shares of Trio-Tech International (NYSE:TRT – Free Report) in a research report released on Monday morning....
SL Green Realty (NYSE:SLG) Upgraded to “Inline” by Evercore ISI
Evercore ISI upgraded shares of SL Green Realty (NYSE:SLG – Free Report) from an underperform rating to an inline rating...
StockNews.com Upgrades Trade Desk (NASDAQ:TTD) to “Buy”
StockNews.com upgraded shares of Trade Desk (NASDAQ:TTD – Free Report) from a hold rating to a buy rating in a...
Morgan Stanley Trims Range Resources (NYSE:RRC) Target Price to $31.00
Range Resources (NYSE:RRC – Free Report) had its price objective decreased by Morgan Stanley from $33.00 to $31.00 in a...
Intra-Cellular Therapies (NASDAQ:ITCI) Earns Overweight Rating from Cantor Fitzgerald
Cantor Fitzgerald reaffirmed their overweight rating on shares of Intra-Cellular Therapies (NASDAQ:ITCI – Free Report) in a research report report...